These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23352041)

  • 1. In vitro antitumor activity of methotrexate via pH-sensitive chitosan nanoparticles.
    Nogueira DR; Tavano L; Mitjans M; Pérez L; Infante MR; Vinardell MP
    Biomaterials; 2013 Apr; 34(11):2758-72. PubMed ID: 23352041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion of a pH-responsive amino acid-based amphiphile in methotrexate-loaded chitosan nanoparticles as a delivery strategy in cancer therapy.
    Nogueira DR; Scheeren LE; Macedo LB; Marcolino AI; Pilar Vinardell M; Mitjans M; Rosa Infante M; Farooqi AA; Rolim CM
    Amino Acids; 2016 Jan; 48(1):157-68. PubMed ID: 26306845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
    Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
    Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan-tripolyphosphate nanoparticles functionalized with a pH-responsive amphiphile improved the in vitro antineoplastic effects of doxorubicin.
    Nogueira-Librelotto DR; Scheeren LE; Vinardell MP; Mitjans M; Rolim CMB
    Colloids Surf B Biointerfaces; 2016 Nov; 147():326-335. PubMed ID: 27543694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
    Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
    ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactobionic acid-modified thymine-chitosan nanoparticles as potential carriers for methotrexate delivery.
    Wang J; Zhang Z; Ai Y; Liu F; Chen MM; Liu D
    Carbohydr Res; 2021 Mar; 501():108275. PubMed ID: 33657498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly (ɛ-Caprolactone) Nanoparticles with pH-Responsive Behavior Improved the In Vitro Antitumor Activity of Methotrexate.
    Macedo LB; Nogueira-Librelotto DR; de Vargas J; Scheeren LE; Vinardell MP; Rolim CMB
    AAPS PharmSciTech; 2019 Apr; 20(5):165. PubMed ID: 30993464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles incorporating pH-responsive surfactants as a viable approach to improve the intracellular drug delivery.
    Nogueira DR; Scheeren LE; Pilar Vinardell M; Mitjans M; Rosa Infante M; Rolim CM
    Mater Sci Eng C Mater Biol Appl; 2015 Dec; 57():100-6. PubMed ID: 26354244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-Sensitive chitosan-tripolyphosphate nanoparticles increase doxorubicin-induced growth inhibition of cervical HeLa tumor cells by apoptosis and cell cycle modulation.
    Nogueira-Librelotto DR; Scheeren LE; Macedo LB; Vinardell MP; Rolim CMB
    Colloids Surf B Biointerfaces; 2020 Jun; 190():110897. PubMed ID: 32126359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, Characterization, and Optimization of Folic Acid-Chitosan-Methotrexate Core-Shell Nanoparticles by Box-Behnken Design for Tumor-Targeted Drug Delivery.
    Naghibi Beidokhti HR; Ghaffarzadegan R; Mirzakhanlouei S; Ghazizadeh L; Dorkoosh FA
    AAPS PharmSciTech; 2017 Jan; 18(1):115-129. PubMed ID: 26896317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and formulation of methotrexate (MTX) conjugated LaF3:Tb(3+)/chitosan nanoparticles for targeted drug delivery applications.
    Mangaiyarkarasi R; Chinnathambi S; Aruna P; Ganesan S
    Biomed Pharmacother; 2015 Feb; 69():170-8. PubMed ID: 25661354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity.
    Chen J; Huang L; Lai H; Lu C; Fang M; Zhang Q; Luo X
    Mol Pharm; 2014 Jul; 11(7):2213-23. PubMed ID: 24164427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose cryoprotectant affects glutathione-responsive antitumor drug release from polysaccharide nanoparticles.
    Curcio M; Blanco-Fernández B; Costoya A; Concheiro A; Puoci F; Alvarez-Lorenzo C
    Eur J Pharm Biopharm; 2015 Jun; 93():281-92. PubMed ID: 25917641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface functionalization of methotrexate-loaded chitosan nanoparticles with hyaluronic acid/human serum albumin: Comparative characterization and in vitro cytotoxicity.
    Hashad RA; Ishak RA; Geneidi AS; Mansour S
    Int J Pharm; 2017 Apr; 522(1-2):128-136. PubMed ID: 28279742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Carrier-Free Folate Receptor-Targeted Ursolic Acid/Methotrexate Nanodelivery System for Synergetic Anticancer Therapy.
    Lan JS; Qin YH; Liu L; Zeng RF; Yang Y; Wang K; Ding Y; Zhang T; Ho RJY
    Int J Nanomedicine; 2021; 16():1775-1787. PubMed ID: 33692622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of pH-sensitive lysozyme/pectin nanogel for tumor methotrexate delivery.
    Lin L; Xu W; Liang H; He L; Liu S; Li Y; Li B; Chen Y
    Colloids Surf B Biointerfaces; 2015 Feb; 126():459-66. PubMed ID: 25601095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan/PLA nanoparticles as a novel carrier for the delivery of anthraquinone: synthesis, characterization and in vitro cytotoxicity evaluation.
    Jeevitha D; Amarnath K
    Colloids Surf B Biointerfaces; 2013 Jan; 101():126-34. PubMed ID: 22796782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization and pH-controllable methotrexate release from biocompatible polymer/silica nanocomposite for anticancer drug delivery.
    Rasouli S; Davaran S; Rasouli F; Mahkam M; Salehi R
    Drug Deliv; 2014 May; 21(3):155-63. PubMed ID: 24107075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
    Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
    Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH/redox responsive core cross-linked nanoparticles from thiolated carboxymethyl chitosan for in vitro release study of methotrexate.
    Gao C; Liu T; Dang Y; Yu Z; Wang W; Guo J; Zhang X; He G; Zheng H; Yin Y; Kong X
    Carbohydr Polym; 2014 Oct; 111():964-70. PubMed ID: 25037437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.